Page last updated: 2024-11-06

guanidine thiocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Guanidine thiocyanate (GuSCN) is a colorless, crystalline salt with a melting point of 118 °C. It is commonly used as a denaturant in protein chemistry. It is synthesized by reacting guanidine carbonate with ammonium thiocyanate. GuSCN disrupts the non-covalent interactions that maintain the structure of proteins, including hydrogen bonds, hydrophobic interactions, and electrostatic interactions. These interactions are essential for protein folding and stability. By disrupting these interactions, GuSCN denatures proteins, unfolding them and exposing their constituent amino acids. This property makes it useful for studying the structure and function of proteins, as well as for purifying and isolating proteins from complex mixtures. GuSCN is also used in the preparation of protein crystals for X-ray crystallography. GuSCN is studied because it is a potent denaturant that can be used to investigate protein structure and function. It is also used in the preparation of protein crystals for X-ray crystallography. Research into GuSCN focuses on its effects on proteins, its mechanism of action, and its potential applications in biotechnology and medicine.'

guanidine thiocyanate: a powerful chaotropic agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65046
SCHEMBL ID28942
MeSH IDM0153719

Synonyms (42)

Synonym
LS-12942
nsc-2119
593-84-0
guanidine thiocyanate
nsc2119
guanidine thiocyanate, for molecular biology, >=99%
guanidine thiocyanate, >=97% (titration)
einecs 209-812-1
nsc 2119
ai3-18430
usaf ek-705
G-8102
G-8100
GTC ,
guanidine thiocyanate, >=97.0% (at)
guanidine thiocyanate, bioreagent, for molecular biology, >=99%
guanidine thiocyanate, bioultra, for molecular biology, >=99.0% (at)
G0360
G0230
AKOS015961014
gca2eu297u ,
unii-gca2eu297u
BP-13066
guanidinium rhodanide
guanidinium isothiocyanate
SCHEMBL28942
DTXSID6060478
guandine thiocyanate
mfcd00013027
guanidine thiocyanate, molecular biology grade
M01833
guanidine thiocyanate, >=99.5%
guanidine thiocyanate, vetec(tm) reagent grade, >=97%
guanidine thiocyanate solu-tion
guanidine;thiocyanic acid
Q904487
guanidine thiocyanate, ultrapure
SY003172
buffer avl
guanidinethiocyanate
CS-0014812
HY-D0841

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Since CJD brain samples are infectious at all stages of the prion extraction process, we set out to develop a laboratory safe method for prion purification."( Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease.
Bastian, FO; Carver, LA; Dash, S; Garry, RF; McDermott, ME; Perry, AS, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (169)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (4.14)18.7374
1990's70 (41.42)18.2507
2000's51 (30.18)29.6817
2010's28 (16.57)24.3611
2020's13 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.76 (24.57)
Research Supply Index5.16 (2.92)
Research Growth Index5.47 (4.65)
Search Engine Demand Index81.08 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other173 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]